BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25488663)

  • 1. A revised mechanism for the activation of complement C3 to C3b: a molecular explanation of a disease-associated polymorphism.
    Rodriguez E; Nan R; Li K; Gor J; Perkins SJ
    J Biol Chem; 2015 Jan; 290(4):2334-50. PubMed ID: 25488663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-association and domain rearrangements between complement C3 and C3u provide insight into the activation mechanism of C3.
    Li K; Gor J; Perkins SJ
    Biochem J; 2010 Oct; 431(1):63-72. PubMed ID: 20666732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc-induced self-association of complement C3b and Factor H: implications for inflammation and age-related macular degeneration.
    Nan R; Tetchner S; Rodriguez E; Pao PJ; Gor J; Lengyel I; Perkins SJ
    J Biol Chem; 2013 Jun; 288(26):19197-210. PubMed ID: 23661701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modelling of human complement component C3 and its fragments by solution scattering.
    Perkins SJ; Sim RB
    Eur J Biochem; 1986 May; 157(1):155-68. PubMed ID: 3486762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domain structure of human complement C4b extends with increasing NaCl concentration: implications for its regulatory mechanism.
    Fung KW; Wright DW; Gor J; Swann MJ; Perkins SJ
    Biochem J; 2016 Dec; 473(23):4473-4491. PubMed ID: 27738201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of the complement system C3 component by HIV-1 proteinase.
    Kisselev AF; Mentele R; von der Helm K
    Biol Chem; 1997 May; 378(5):439-42. PubMed ID: 9191031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement C3b interactions studied with surface plasmon resonance technique.
    Jokiranta TS; Westin J; Nilsson UR; Nilsson B; Hellwage J; Löfås S; Gordon DL; Ekdahl KN; Meri S
    Int Immunopharmacol; 2001 Mar; 1(3):495-506. PubMed ID: 11367533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of TT30, a novel complement therapeutic agent, provides insight into its joint binding to complement C3b and C3d.
    Li K; Gor J; Holers VM; Storek MJ; Perkins SJ
    J Mol Biol; 2012 May; 418(3-4):248-63. PubMed ID: 22387467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
    J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A; Isaacs SN; Soulika AM; Lambris JD
    J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Binding Properties of Individual Functional Sites of Human Complement Factor H.
    Haque A; Cortes C; Alam MN; Sreedhar M; Ferreira VP; Pangburn MK
    Front Immunol; 2020; 11():1728. PubMed ID: 32849614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights on complement activation.
    Alcorlo M; López-Perrote A; Delgado S; Yébenes H; Subías M; Rodríguez-Gallego C; Rodríguez de Córdoba S; Llorca O
    FEBS J; 2015 Oct; 282(20):3883-91. PubMed ID: 26250513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of complement C3b provides insights into complement activation and regulation.
    Abdul Ajees A; Gunasekaran K; Volanakis JE; Narayana SV; Kotwal GJ; Murthy HM
    Nature; 2006 Nov; 444(7116):221-5. PubMed ID: 17051152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimeric interactions between complement factor H and its C3d ligand provide new insight on complement regulation.
    Okemefuna AI; Li K; Nan R; Ormsby RJ; Sadlon T; Gordon DL; Perkins SJ
    J Mol Biol; 2009 Aug; 391(1):119-35. PubMed ID: 19505474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of fibronectin with complement component C3.
    Hautanen A; Keski-Oja J
    Scand J Immunol; 1983 Mar; 17(3):225-30. PubMed ID: 6402811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two distinct conformations of factor H regulate discrete complement-binding functions in the fluid phase and at cell surfaces.
    Osborne AJ; Nan R; Miller A; Bhatt JS; Gor J; Perkins SJ
    J Biol Chem; 2018 Nov; 293(44):17166-17187. PubMed ID: 30217822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
    Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
    Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides.
    Lambris JD; Avila D; Becherer JD; Müller-Eberhard HJ
    J Biol Chem; 1988 Aug; 263(24):12147-50. PubMed ID: 2969896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining SPR with atomic-force microscopy enables single-molecule insights into activation and suppression of the complement cascade.
    Makou E; Bailey RG; Johnston H; Parkin JD; Hulme AN; Hähner G; Barlow PN
    J Biol Chem; 2019 Dec; 294(52):20148-20163. PubMed ID: 31719147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.